Clinical significance of muscle layer interruption in T3 esophageal cancer

Keijiro Sugimura, Hiroshi Miyata, Makoto Yamasaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Masaaki Motoori, Kiyokazu Nakajima, Shuji Takiguchi, Eiichi Morii, Masahiko Yano, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

Abstract

Background: Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods: Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results: Patients were classified as T1 (38.4 %), T2 (11.9 %), T3 (38.4 %), and T4 (11.2 %) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 %, p = 0.009). T3 tumors with <20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 %), whereas those with ≥20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 %). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with ≥20 mm MLI than in those with <20 mm MLI (4.3 vs. 21.4 %, p = 0.019). Conclusions: T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with >20 mm MLI.

Original languageEnglish
Pages (from-to)117-125
Number of pages9
JournalEsophagus
Volume11
Issue number2
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Esophageal Neoplasms
Muscles
Adventitia
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Sugimura, K., Miyata, H., Yamasaki, M., Takahashi, T., Kurokawa, Y., Motoori, M., ... Doki, Y. (2014). Clinical significance of muscle layer interruption in T3 esophageal cancer. Esophagus, 11(2), 117-125. https://doi.org/10.1007/s10388-014-0420-1

Clinical significance of muscle layer interruption in T3 esophageal cancer. / Sugimura, Keijiro; Miyata, Hiroshi; Yamasaki, Makoto; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Motoori, Masaaki; Nakajima, Kiyokazu; Takiguchi, Shuji; Morii, Eiichi; Yano, Masahiko; Mori, Masaki; Doki, Yuichiro.

In: Esophagus, Vol. 11, No. 2, 01.01.2014, p. 117-125.

Research output: Contribution to journalArticle

Sugimura, K, Miyata, H, Yamasaki, M, Takahashi, T, Kurokawa, Y, Motoori, M, Nakajima, K, Takiguchi, S, Morii, E, Yano, M, Mori, M & Doki, Y 2014, 'Clinical significance of muscle layer interruption in T3 esophageal cancer', Esophagus, vol. 11, no. 2, pp. 117-125. https://doi.org/10.1007/s10388-014-0420-1
Sugimura K, Miyata H, Yamasaki M, Takahashi T, Kurokawa Y, Motoori M et al. Clinical significance of muscle layer interruption in T3 esophageal cancer. Esophagus. 2014 Jan 1;11(2):117-125. https://doi.org/10.1007/s10388-014-0420-1
Sugimura, Keijiro ; Miyata, Hiroshi ; Yamasaki, Makoto ; Takahashi, Tsuyoshi ; Kurokawa, Yukinori ; Motoori, Masaaki ; Nakajima, Kiyokazu ; Takiguchi, Shuji ; Morii, Eiichi ; Yano, Masahiko ; Mori, Masaki ; Doki, Yuichiro. / Clinical significance of muscle layer interruption in T3 esophageal cancer. In: Esophagus. 2014 ; Vol. 11, No. 2. pp. 117-125.
@article{398a89c633804b3b9acb8abf2f76ba25,
title = "Clinical significance of muscle layer interruption in T3 esophageal cancer",
abstract = "Background: Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods: Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results: Patients were classified as T1 (38.4 {\%}), T2 (11.9 {\%}), T3 (38.4 {\%}), and T4 (11.2 {\%}) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 {\%}, p = 0.009). T3 tumors with <20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 {\%}), whereas those with ≥20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 {\%}). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with ≥20 mm MLI than in those with <20 mm MLI (4.3 vs. 21.4 {\%}, p = 0.019). Conclusions: T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with >20 mm MLI.",
author = "Keijiro Sugimura and Hiroshi Miyata and Makoto Yamasaki and Tsuyoshi Takahashi and Yukinori Kurokawa and Masaaki Motoori and Kiyokazu Nakajima and Shuji Takiguchi and Eiichi Morii and Masahiko Yano and Masaki Mori and Yuichiro Doki",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10388-014-0420-1",
language = "English",
volume = "11",
pages = "117--125",
journal = "Esophagus",
issn = "1612-9059",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Clinical significance of muscle layer interruption in T3 esophageal cancer

AU - Sugimura, Keijiro

AU - Miyata, Hiroshi

AU - Yamasaki, Makoto

AU - Takahashi, Tsuyoshi

AU - Kurokawa, Yukinori

AU - Motoori, Masaaki

AU - Nakajima, Kiyokazu

AU - Takiguchi, Shuji

AU - Morii, Eiichi

AU - Yano, Masahiko

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods: Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results: Patients were classified as T1 (38.4 %), T2 (11.9 %), T3 (38.4 %), and T4 (11.2 %) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 %, p = 0.009). T3 tumors with <20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 %), whereas those with ≥20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 %). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with ≥20 mm MLI than in those with <20 mm MLI (4.3 vs. 21.4 %, p = 0.019). Conclusions: T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with >20 mm MLI.

AB - Background: Patients with adventitia-invading (T3) tumors, which account for the majority of esophageal cancers, are indicated for surgery but still have a poor prognosis. Subclassifying T3 tumors based on clinical outcome would be useful for selecting adequate adjuvant therapies. Methods: Using 268 esophageal cancer specimens from patients without preoperative treatment, the length of the vertical and longitudinal tumor invasion, entire esophageal wall thickness, and interruption of the outer muscle layer were measured. These morphological parameters correlated with clinico-pathological factors and outcome. Results: Patients were classified as T1 (38.4 %), T2 (11.9 %), T3 (38.4 %), and T4 (11.2 %) and T stage correlated well with the four morphological parameters (p < 0.0001). Each of the four morphological parameters was a significant prognostic factor. A cutoff at 20 mm of muscle layer interruption (MLI) yielded the highest prognostic significance (5-year survival 36.7 vs. 59.1 %, p = 0.009). T3 tumors with <20 mm MLI showed survival rates equivalent to T2 tumors (5-year survival 59.5 %), whereas those with ≥20 mm MLI had survival rates similar to T4 tumors (5-year survival 26.7 %). Although lymphatic and hematogenic recurrence was not significantly different, local recurrences occurred more frequently in patients with T3 tumors with ≥20 mm MLI than in those with <20 mm MLI (4.3 vs. 21.4 %, p = 0.019). Conclusions: T3 esophageal cancer can be classified into subgroups according to the length of MLI. Additional local treatment would be indicated for T3 tumors with >20 mm MLI.

UR - http://www.scopus.com/inward/record.url?scp=84898799948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898799948&partnerID=8YFLogxK

U2 - 10.1007/s10388-014-0420-1

DO - 10.1007/s10388-014-0420-1

M3 - Article

VL - 11

SP - 117

EP - 125

JO - Esophagus

JF - Esophagus

SN - 1612-9059

IS - 2

ER -